Harbor Capital Advisors, Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.29 Billion
- Q4 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 22,113 shares of TARS stock, worth $1.14 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
22,113
Previous 18,105
22.14%
Holding current value
$1.14 Million
Previous $595,000
105.71%
% of portfolio
0.05%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
200Shares Held
40.4MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$169 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$167 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$131 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$129 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$117 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.38B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...